Suchergebnisse - "Nayak, Surendra Kumar"

PubPharm (9)

1

A Review on Anticancer Profile of Flavonoids : Sources, Chemistry, Mechanisms, Structure-activity Relationship and Anticancer Activity

enthalten in: Current drug research reviews | 2023

von Shah, S. | Narang, R. | Singh, V. | +2

2

Alpha-amylase as molecular target for treatment of diabetes mellitus : A comprehensive review

enthalten in: Chemical biology & drug design | 2021

von Kaur, N. | Kumar, V. | Nayak, S. | +3

3

Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19)

enthalten in: Mini reviews in medicinal chemistry | 2021

von Nayak, S.

4

An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus

enthalten in: Current diabetes reviews | 2020

von Bashary, R. | Vyas, M. | Nayak, S. | +4

5

Recent advancements in mechanistic studies and structure activity relationship of FoF1 ATP synthase inhibitor as antimicrobial agent

enthalten in: European journal of medicinal chemistry | 2019

von Narang, R. | Kumar, R. | Kalra, S. | +5

6

A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery and Developments

enthalten in: Current drug discovery technologies | 2018

von Khatik, G. | Datusalia, A. | Ahsan, W. | +4

7

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

enthalten in: Current cancer drug targets | 2018

von Nayak, S. | Khatik, G. | Narang, R. | +2

8

Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus

enthalten in: Current drug targets | 2018

von Kaur, P. | Mittal, A. | Nayak, S. | +3

9

p53-Induced apoptosis and inhibitors of p53

enthalten in: Current medicinal chemistry | 2009

von Nayak, S. | Panesar, P. | Kumar, H.

1
[1]